Recognized as Place of research
07
Jun
Share
No Comments on Nine Biopharma Trends to Watch in 2022 Uncategorized
Nine Biopharma Trends to Watch in 2022
Biomedical breakthroughs in recent years have been revolutionary, and they are likely to cause substantial industry upheavals shortly, drawing new investors and shaping the R&D focus of the next decade. This blog post highlights new market players and critical R&D achievements and[…]
Read More07
Jun
Share
No Comments on Advantages of Hybridoma vs Phage Display for Monoclonal Antibody Production Monoclonal Antibodies
Advantages of Hybridoma vs Phage Display for Monoclonal Antibody Production
What level of antibody affinity do you require? What will your project’s final application be? Do you have any limits in terms of time or money? If you’re deciding between hybridoma technology steps and phage display for a monoclonal antibodies production project[…]
Read More06
Jun
Share
No Comments on Production of Monoclonal Antibodies Monoclonal Antibodies
Production of Monoclonal Antibodies
The definitive monoclonal antibody (mAb) production procedure involves fusing myeloma cells with desired antibody-producing splenocytes to produce mAb-producing cells (hybridomas) (e.g. B cells). Animals, mainly mice, are used to obtain these B cells; following cell fusion, thousands of clones are screened[…]
Read More28
Apr
Share
No Comments on Similarities Between Chimeric And Humanized Antibodies Antibody
Similarities Between Chimeric And Humanized Antibodies
Chimeric and humanized antibodies are monoclonal antibodies that are non-human and are set into production by mice or rodents under specific laboratory conditions. Chimeric antibody usually tracks down and illuminize the tumour regions, whereas the humanized antibodies antigenic region is derived from[…]
Read More01
Apr
Share
No Comments on SARS-CoV-2 Neutralizing Antibody Response Dynamics: Methods Biologics, Recombinant Protein
SARS-CoV-2 Neutralizing Antibody Response Dynamics: Methods
The COVID-19 Pandemic has caused a lot of commotion globally, and with SARS-COV-2 Spike Protein causing it, there has been a surge for over a year now, with no positive sign of it ending and normalizing life. With the Pandemic affecting people,[…]
Read More30
Mar
Share
No Comments on Advantage of Using Monoclonal over polyclonal Antibody Monoclonal Antibodies
Advantage of Using Monoclonal over polyclonal Antibody
Antibodies are giant Y shaped proteins known as immunoglobulins produced by B cells as a part of the flexible human response when encountering a foreign molecule. Many researchers employ epitopes to identify and detect the target protein of interest in various applications[…]
Read More01
Mar
Share
No Comments on Steps Involved in Hybridoma Technology Monoclonal Antibodies
Steps Involved in Hybridoma Technology
Hybridoma technology steps are a series of entrenched methods to produce mAbs ( monoclonal antibodies) to antigens of interest. Hybridoma cell lines are formed by combining a short-lived antibody-producing B cell and an immortal myeloma cell. Every hybridoma constitutively conveys a considerable[…]
Read More01
Mar
Share
No Comments on Effective Methods For Purifying Protein Recombinant Protein
Effective Methods For Purifying Protein
What is purified protein? Protein purification is necessary to identify the structures and functions before the study. It involves many steps, from disrupting the cells and isolating the proteins to removing impurities. If you require the protein purification process, you have samples[…]
Read More01
Mar
Share
No Comments on Cytokine Storm in COVID-19 Cytokines
Cytokine Storm in COVID-19
The present situation demonstrated that many ill patients tend to have a high concentration of proinflammatory Cytokines, like interleukin-6, differentiated to moderately sick ones. The high level of cytokines indicates a prognosis in coronavirus. We summarise the clinical and pathologic aspects of[…]
Read More25
Feb
Share
No Comments on How Does Monoclonal Antibody Therapy Work? Monoclonal Antibodies
How Does Monoclonal Antibody Therapy Work?
Recently, FDA (Food and Drug Administration) has enlarged the potential application of mAb (monoclonal antibody) therapy for inhibitory use, which are at serious risk due to a confirmed exposure to the virus. The permission was based on a substantial clinical trial that[…]
Read MoreRecent Posts
Nine Biopharma Trends to Watch in 2022
